Agilon Health (NYSE:AGL) Shares Down 6.1% – Here’s What Happened

Agilon Health, Inc. (NYSE:AGL) dropped 6.1% on Wednesday . The stock traded as low as $107.75 and last traded at $106.3050. 18,677 shares were traded during trading, a decline of 95% from the average daily volume of 350,562 shares. The stock had previously closed at $113.27.

Wall Street Analyst Weigh In

Several research firms have weighed in on AGL. Citigroup reiterated a “neutral” rating and issued a $80.00 price objective (up from $18.75) on shares of Agilon Health in a research note on Friday, May 15th. Deutsche Bank Aktiengesellschaft upgraded Agilon Health from a “hold” rating to a “buy” rating and raised their target price for the company from $33.00 to $49.00 in a report on Thursday, May 7th. TD Cowen reissued a “hold” rating and set a $55.00 price objective (up from $17.00) on shares of Agilon Health in a report on Monday, May 11th. Benchmark restated a “buy” rating and issued a $95.00 target price (up from $13.00) on shares of Agilon Health in a report on Thursday, May 21st. Finally, JPMorgan Chase & Co. cut Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 target price for the company. in a research report on Monday, May 4th. Five equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $58.73.

Agilon Health Price Performance

The company has a market capitalization of $1.88 billion, a P/E ratio of -5.23 and a beta of 3.02. The stock’s fifty day simple moving average is $65.03 and its 200-day simple moving average is $33.45. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04.

Agilon Health (NYSE:AGL) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. On average, equities analysts forecast that Agilon Health, Inc. will post -3.5 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Wealthcare Advisory Partners LLC acquired a new stake in shares of Agilon Health in the third quarter worth $26,000. LPL Financial LLC raised its stake in Agilon Health by 213.4% during the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after purchasing an additional 30,000 shares during the last quarter. Krilogy Financial LLC bought a new stake in Agilon Health in the 4th quarter valued at $34,000. CIBC Bancorp USA Inc. bought a new stake in Agilon Health in the 3rd quarter valued at $34,000. Finally, Merit Financial Group LLC acquired a new stake in Agilon Health in the 4th quarter worth $35,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.